These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34240695)

  • 1. Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021.
    Ito K; Piantham C; Nishiura H
    Euro Surveill; 2021 Jul; 26(27):. PubMed ID: 34240695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not all fun and games: Potential incidence of SARS-CoV-2 infections during the Tokyo 2020 Olympic Games.
    Linton NM; Jung SM; Nishiura H
    Math Biosci Eng; 2021 Nov; 18(6):9685-9696. PubMed ID: 34814363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to COVID-19 during the Tokyo Olympic Games: Did we properly assess the risk?
    Jung SM; Hayashi K; Kayano T; Nishiura H
    Epidemics; 2022 Sep; 40():100618. PubMed ID: 35908478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Infection upon Leaving the Tokyo 2020 Olympic and Paralympic Games.
    Urashima M; Takao H; Sakano T; Takeshita K; Yoshida M; Nakazawa Y; Kawai M; Murayama Y
    Intern Med; 2022 Dec; 61(24):3659-3666. PubMed ID: 36198605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and Heat Illness in Tokyo, Japan: Implications for the Summer Olympic and Paralympic Games in 2021.
    Shimizu K; Gilmour S; Mase H; Le PM; Teshima A; Sakamoto H; Nomura S
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33807268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 infection during the Olympic and Paralympic Games Tokyo 2020.
    Yashio T; Murayama A; Kami M; Ozaki A; Tanimoto T; Rodriguez-Morales AJ
    Travel Med Infect Dis; 2021; 44():102205. PubMed ID: 34785374
    [No Abstract]   [Full Text] [Related]  

  • 7. Estimating COVID-19 cases infected with the variant alpha (VOC 202012/01): an analysis of screening data in Tokyo, January-March 2021.
    Murayama H; Kayano T; Nishiura H
    Theor Biol Med Model; 2021 Jul; 18(1):13. PubMed ID: 34273991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic: planning, outcomes, and lessons learnt.
    McCloskey B; Saito T; Shimada S; Ikenoue C; Endericks T; Mullen L; Mota P; Kumar CK; Laxminarayan R; Budgett R; Heymann D; Zumla A
    Lancet; 2024 Feb; 403(10425):493-502. PubMed ID: 38244561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The strategy behind Japan's response to COVID-19 from 2020-2021 and future challenges posed by the uncertainty of the Omicron variant in 2022.
    Song P; Karako T
    Biosci Trends; 2022 Jan; 15(6):350-352. PubMed ID: 34980786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Border Transmissions of the Delta Substrain AY.29 During Tokyo Olympic and Paralympic Games.
    Koyama T; Tokumasu R; Katayama K; Saito A; Kudo M; Imoto S
    Front Microbiol; 2022; 13():883849. PubMed ID: 35992703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Chaotic Behavior of the Spread of Infection during the COVID-19 Pandemic in Japan.
    Sapkota N; Murata A; Karwowski W; Davahli MR; Fiok K; Aljuaid AM; Marek T; Ahram T
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36232099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The COVID-19 outbreak and implications for the Tokyo 2020 Summer Olympic Games.
    Gallego V; Nishiura H; Sah R; Rodriguez-Morales AJ
    Travel Med Infect Dis; 2020; 34():101604. PubMed ID: 32112859
    [No Abstract]   [Full Text] [Related]  

  • 13. SARS-CoV-2 Infection among Medical Institution Faculty and Healthcare Workers in Tokyo, Japan.
    Nishimura T; Uwamino Y; Uno S; Kashimura S; Shiraki T; Kurafuji T; Morita M; Noguchi M; Azegami T; Yamada-Goto N; Murai-Takeda A; Yokoyama H; Kuwabara K; Kato S; Matsumoto M; Hirata A; Iida M; Harada S; Ishizaka T; Misawa K; Murata M; Saya H; Amagai M; Kitagawa Y; Takeuchi T; Mori M; Takebayashi T; Hasegawa N;
    Intern Med; 2021 Aug; 60(16):2569-2575. PubMed ID: 34148952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causal Effect of the Tokyo 2020 Olympic and Paralympic Games on the Number of COVID-19 Cases under COVID-19 Pandemic: An Ecological Study Using the Synthetic Control Method.
    Yamamoto N; Mitsuhashi T; Tsuchihashi Y; Yorifuji T
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the Trajectory of Replacements of SARS-CoV-2 Variants Using Relative Reproduction Numbers.
    Piantham C; Ito K
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021.
    Malden DE; Bruxvoort KJ; Tseng HF; Ackerson B; Choi SK; Florea A; Tubert J; Takhar H; Aragones M; Hong V; Talarico CA; McLaughlin JM; Qian L; Tartof SY
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(40):1415-1419. PubMed ID: 34618801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Risk Assessment for the Tokyo Olympic Games.
    Zhu W; Feng J; Li C; Wang H; Zhong Y; Zhou L; Zhang X; Zhang T
    Front Public Health; 2021; 9():730611. PubMed ID: 34760863
    [No Abstract]   [Full Text] [Related]  

  • 18. The COVID-19 athlete passport: a tool for managing athlete COVID-19 status surrounding the Tokyo 2020 Olympic games.
    McLarnon M; Heron N
    Phys Sportsmed; 2021 Nov; 49(4):367-370. PubMed ID: 33535866
    [No Abstract]   [Full Text] [Related]  

  • 19. Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.
    Tanaka A; Yamamoto S; Miyo K; Mizoue T; Maeda K; Sugiura W; Mitsuya H; Sugiyama H; Ohmagari N
    J Infect; 2021 Apr; 82(4):e1-e3. PubMed ID: 33524423
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced event-based surveillance for imported diseases during the Tokyo 2020 Olympic and Paralympic Games.
    Kasamatsu A; Ota M; Shimada T; Fukusumi M; Yamagishi T; Samuel A; Nakashita M; Ukai T; Kurosawa K; Urakawa M; Takahashi K; Tsukada K; Futami A; Inoue H; Omori S; Kobayashi M; Komiya H; Shimada T; Tabata S; Yahata Y; Kamiya H; Yoshimatsu F; Sunagawa T; Saito T
    Western Pac Surveill Response J; 2021; 12(4):1-7. PubMed ID: 35251745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.